Physician

Stuart A. Fox, M.D.

According to 2025 Medicare claims, Stuart Fox, M.D. (NPI: 1366472235) practices obstetrics/gynecology in the Racine-Mount Pleasant, WI market, with the plurality of this provider's patient population coming from Racine, WI. This provider's primary affiliated billing organization is ASCENSION MEDICAL GROUP-SOUTHEAST WISCONSIN INC (NPI: 1609881077; TIN: 391791586) and primary practice location at 53177-1604. Fox is affiliated with the Ascension Care Management Health Partners Wisconsin, LLC (ACO ID: A5329), participating under the MSSP model.

Fox's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 175 traditional Medicare patients, billed 5,006 HCPCS/CPT codes, and received $88,305 in Medicare payments. The top billing code was 52287 (Exam with injections of chemical for destruction of bladder using an endoscope). Part D data shows 1,916 prescription claims across 430 beneficiaries totaling $463,204 in drug costs, led by Myrbetriq (Mirabegron). 2016 DME data shows 12 claims. Open Payments data shows 13 records totaling $1,440. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $64,289 and ending at $88,305. Concurrently, Part D prescription costs have risen steadily, from $197,919 to $463,204. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	229	849	$64,289
2016	221	1,035	$79,728
2017	259	1,092	$72,877
2018	238	846	$61,195
2019	230	891	$52,833
2020	159	4,191	$89,068
2021	167	3,789	$94,764
2022	154	3,319	$67,508
2023	149	4,014	$63,579
2024	175	5,006	$88,305

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	258	1,093	$197,919
2016	270	1,048	$202,344
2017	319	1,509	$299,842
2018	325	1,420	$329,197
2019	352	1,498	$328,738
2020	310	1,428	$319,413
2021	309	1,437	$317,205
2022	332	1,574	$329,543
2023	383	1,800	$430,761
2024	430	1,916	$463,204

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	12	$3,052
2016	N/R	12	$3,022
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
52287	Exam with injections of chemical for destruction of bladder using an endoscope	34	42	$273
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	60	83	$80
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	68	115	$58
99212	Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more	43	50	$38
J0585	Injection, onabotulinumtoxina, 1 unit	35	4,300	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Myrbetriq	Mirabegron	519	22,380	$342,689
Premarin	Estrogens, Conjugated	103	6,238	$46,660
Estradiol	Estradiol	236	18,329	$15,037
Elmiron	Pentosan Polysulfate Sodium	12	360	$8,923
Femring	Estradiol Acetate	12	1,080	$8,304

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	13	$1,440	Axonics, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Stuart A. Fox, M.D.?

Tedicare shows public-source Medicare data for Stuart A. Fox, M.D. (NPI 1366472235), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Stuart A. Fox, M.D. have ACO affiliation data?

Stuart A. Fox, M.D. is shown with ACO affiliation data for Ascension Care Management Health Partners Wisconsin, LLC (MSSP, ACO ID A5329).

What billing organization is linked to Stuart A. Fox, M.D.?

Stuart A. Fox, M.D. is linked to ASCENSION MEDICAL GROUP-SOUTHEAST WISCONSIN INC (billing NPI 1609881077) in the available physician profile data.

Does Stuart A. Fox, M.D. have Open Payments data?

Stuart A. Fox, M.D. has 13 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.